ZYBERNO
Stock Report
Updated Sep 1, 2026

RETRACTABLE TECHNOLOGIES INC (RVP)

Healthcare • NYSE

$0.73

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
14.0/100
POOR BUSINESS
RETRACTABLE TECHNOLOGIES INC (RVP) scores 14/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-4.6%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.01x)
Operating Margin (Operational Efficiency):CRITICAL (-66.9%)
Return on Capital (Capital Efficiency):CRITICAL (-18.1%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

RETRACTABLE TECHNOLOGIES INC (RVP) stock report — Zyberno Score 14/100 (POOR BUSINESS). Full financial analysis on Zyberno.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:0.73
Market Cap:$21.91M

Valuation Multiples (3)

P/B Ratio:0.30x
P/S Ratio:0.65x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$74.52M

Price Action & Momentum (3)

Momentum Percentile:56 / 100
% of 52-Week High:64.2%
B. Profitability Assessment

Return Metrics (5)

ROA:-2.4%
Reinvestment Rate:27.9%
Fundamental Growth Rate (g):-5.0%

Margin Analysis (3)

Operating Margin Ttm:-66.9%
Net Margin Ttm:-9.9%
Ebitda Margin:-43.9%

TTM Performance (3)

Gross Margin Ttm:-7.1%
Operating Margin Ttm:-66.9%
Net Margin Ttm:-9.9%

Yield Metrics (2)

Earnings Yield:-$18.77
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:192.3%
Latest Earnings Filed:2026-08-14

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):-14.2%

Earnings Growth (Linear) (1)

Net Income Growth Rate (Linear):-16.8%

Cash Flow Growth (Linear) (1)

Free Cash Flow Growth Rate (Linear):-28.7%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:4.93x
Quick Ratio:3.74x
Cash Ratio:0.20x

Leverage Analysis (3)

Debt To Equity Ttm:0.01x
Debt-to-Equity Ratio:0.01x
Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-260.34x
Times Interest Earned:-260.34

Capital Structure (4)

Working Capital:52,558,688.00
Cash And Cash Equivalents:2,641,041.00
Long Term Debt:$55.13M
Net Debt:$52.61M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $33.90M
Linear Growth: -14.2%
📊 Click to view full RVP Revenue analysis & methodology →
Cost Of Revenue Ttm:$34.39M

Profitability Breakdown (2)

Gross profit TTM: -$2.39M
Linear Growth: -50.0%
📊 Click to view full RVP Gross Profit analysis & methodology →
-$22.68M

Bottom Line Performance (3)

Net income TTM: -$3.37M
Linear Growth: -16.8%
📊 Click to view full RVP Net Income analysis & methodology →
Income Before Tax:-$3.36M
Ebitda Ttm:-14,893,489.00

Operating Expenses (5)

Operating Expenses:22,189,903.00
R And D Expense:682,033.00
Sga Expense:13,728,421.00
Income Tax Expense:$7.39K
Interest Expense:81,338.00

Expense Ratios (3)

R And D To Revenue Percentage:9.5%
Sga To Revenue Percentage:190.7%
Ebitda Margin:-43.9%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$141.69M
Current Assets:$65.92M
Ppe Net:75,465,103.00
Goodwill:0.00
Intangible Assets:$0.00

Liability Structure (4)

Total Liabilities:68,829,302.00
Current Liabilities:13,365,202.00
Long Term Debt:$55.13M
Short Term Debt:$120.16K

Equity & Capital (3)

Equity:$72.87M
Retained Earnings:$12.36M
Common Stock:100,000,000.00

Working Capital Items (3)

Accounts Receivable:9,029,658.00
Inventory:15,934,027.00
Accounts Payable:6,700,860.00

Special Items (2)

Contract Liabilities:1,092,859.00
Stock Based Compensation:1,157,236.00
C. Cash Flow Analysis

Operating Activities (2)

-$6.96M
Free cash flow TTM: -$8.50M
Linear Growth: -28.7%
📊 Click to view full RVP Free Cash Flow analysis & methodology →

Investment Activities (1)

Investing Cash Flow:$1.69M

Financing Activities (3)

Financing Cash Flow:-$146.82K
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$89.21K

Non-Cash Items (1)

Depreciation Amortization Ttm:7,787,923.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-0.13
Eps diluted TTM: -$0.13
Linear Growth: -16.4%
📊 Click to view full RVP EPS analysis & methodology →
Earnings Per Share Ttm:-$0.11

Revenue & Cash Per Share (2)

Sales Per Share Ttm:1.13
Operating Cash Flow Per Share:-$0.24

Book Value & Capital (2)

Book Value Per Share:$2.43
Cash Per Share:0.09

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.24x
Working Capital Turnover Ttm:0.65x

Receivables Management (2)

Receivables Turnover Ttm:3.75x
Days Sales Outstanding Ttm:97.21

Inventory Management (2)

Inventory Turnover Ttm:2.16x
Days Inventory Outstanding Ttm:169.09

Payables & Cash Cycle (2)

Days Payable Outstanding:71.11
Cash Conversion Cycle:195.20
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:40.00
Quality Score:25.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Damodaran Growth Analysis (2)

Reinvestment Rate:27.9%
Fundamental Growth Rate (g):-5.0%
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (2)

Revenue Growth Rate (Linear):-14.2%
Net Income Growth Rate (Linear):-16.8%

Cash Flow Growth Rates (1)

Free Cash Flow Growth Rate (Linear):-28.7%

Other Growth Rates (2)

Gross Profit Growth Rate (Linear):-50.0%
Book Value Growth Rate (Linear):-10.4%
C. Company Profile & Context

Corporate Information (6)

Symbol:RVP
Company Name:RETRACTABLE TECHNOLOGIES INC
Sector:Healthcare
Industry:Medical Devices
Exchange:NYSE
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:penny
Volume Category:N/A

Share Structure (3)

Shares Outstanding:29.94M
Shares Outstanding Basic:29.94M
Shares Outstanding Diluted:29.94M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-09-01 11:51:09 UTC
Data Timestamp:2026-08-21T04:24:31.462575
Scroll to Top